• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Variation in Bile Microbiome by the Etiology of Cholestatic Liver Disease.

作者信息

Tyc Olaf, Jansen Christian, Schierwagen Robert, Uschner Frank Erhard, Israelsen Mads, Klein Sabine, Ortiz Cristina, Strassburg Christian P, Zeuzem Stefan, Gu Wenyi, Torres Sandra, Praktiknjo Michael, Kersting Stephan, Langheinrich Melanie, Nattermann Jacob, Servant Florence, Arumugam Manimozhiyan, Krag Aleksander, Lelouvier Benjamin, Weismüller Tobias J, Trebicka Jonel

机构信息

Translational Hepatology, Department of Internal Medicine I, University Hospital Frankfurt, Goethe University, Frankfurt, Germany.

Department of Internal Medicine I, University Hospital Bonn, University of Bonn, Bonn, Germany.

出版信息

Liver Transpl. 2020 Dec;26(12):1652-1657. doi: 10.1002/lt.25882. Epub 2020 Oct 7.

DOI:10.1002/lt.25882
PMID:32885580
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8462439/
Abstract
摘要

相似文献

1
Variation in Bile Microbiome by the Etiology of Cholestatic Liver Disease.胆汁微生物群因胆汁淤积性肝病病因的变化。
Liver Transpl. 2020 Dec;26(12):1652-1657. doi: 10.1002/lt.25882. Epub 2020 Oct 7.
2
Bile acids and intestinal microbiota in autoimmune cholestatic liver diseases.胆汁酸与自身免疫性胆汁淤积性肝病的肠道微生物群。
Autoimmun Rev. 2017 Sep;16(9):885-896. doi: 10.1016/j.autrev.2017.07.002. Epub 2017 Jul 8.
3
Crosstalk between Gut Microbiota and Bile Acids in Cholestatic Liver Disease.胆汁淤积性肝病中肠道微生物群与胆汁酸的相互作用。
Nutrients. 2023 May 22;15(10):2411. doi: 10.3390/nu15102411.
4
[The intestinal microflora and cholestatic liver diseases].[肠道微生物群与胆汁淤积性肝病]
Zhonghua Gan Zang Bing Za Zhi. 2019 May 20;27(5):325-329. doi: 10.3760/cma.j.issn.1007-3418.2019.05.002.
5
[The descending pathophysiology model of cholestatic liver disease].[胆汁淤积性肝病的下行病理生理学模型]
Zhonghua Gan Zang Bing Za Zhi. 2019 May 20;27(5):321-324. doi: 10.3760/cma.j.issn.1007-3418.2019.05.001.
6
Conditional loss of geranylgeranyl diphosphate synthase alleviates acute obstructive cholestatic liver injury by regulating hepatic bile acid metabolism.条件性敲除香叶基香叶基二磷酸合酶通过调节肝内胆汁酸代谢缓解急性梗阻性胆汁淤积性肝损伤。
FEBS J. 2020 Aug;287(15):3328-3345. doi: 10.1111/febs.15204. Epub 2020 Jan 20.
7
Hepatic levels of bile acids in end-stage chronic cholestatic liver disease.
Clin Chim Acta. 1996 Jul 30;251(2):173-86. doi: 10.1016/0009-8981(96)06305-x.
8
TGR5 signaling mitigates parenteral nutrition-associated liver disease.TGR5 信号转导可减轻肠外营养相关性肝病。
Am J Physiol Gastrointest Liver Physiol. 2020 Feb 1;318(2):G322-G335. doi: 10.1152/ajpgi.00216.2019. Epub 2020 Jan 6.
9
Bile duct-associated macrophages enter the spotlight in inflammatory cholestatic liver disease.
Hepatology. 2024 Feb 1;79(2):257-260. doi: 10.1097/HEP.0000000000000576. Epub 2023 Aug 22.
10
Serotonin protects mouse liver from cholestatic injury by decreasing bile salt pool after bile duct ligation.血清素通过减少胆管结扎后的胆汁盐池来保护小鼠肝脏免受胆汁淤积性损伤。
Hepatology. 2012 Jul;56(1):209-18. doi: 10.1002/hep.25626. Epub 2012 Jun 5.

引用本文的文献

1
Distinct gut microbiome features characterize infection and predict triclabendazole treatment outcomes in Peruvian patients.独特的肠道微生物群特征可表征秘鲁患者的感染情况并预测三氯苯达唑的治疗效果。
Front Cell Infect Microbiol. 2025 Mar 10;15:1555171. doi: 10.3389/fcimb.2025.1555171. eCollection 2025.
2
aggravates cholestatic liver disease by increasing intestinal permeability and enhancing bile acid reabsorption.通过增加肠道通透性和增强胆汁酸重吸收来加重胆汁淤积性肝病。
World J Gastroenterol. 2025 Mar 14;31(10):101014. doi: 10.3748/wjg.v31.i10.101014.
3
Clonorchis sinensis infection induces pathological changes in feline bile duct epithelium and alters biliary microbiota composition.

本文引用的文献

1
Alterations of the bile microbiome in primary sclerosing cholangitis.原发性硬化性胆管炎胆汁微生物组的改变。
Gut. 2020 Apr;69(4):665-672. doi: 10.1136/gutjnl-2019-318416. Epub 2019 Jun 26.
2
Compartmentalization of Immune Response and Microbial Translocation in Decompensated Cirrhosis.代偿期肝硬化中免疫应答和微生物易位的分隔化。
Front Immunol. 2019 Feb 8;10:69. doi: 10.3389/fimmu.2019.00069. eCollection 2019.
3
Circulating microbiome in blood of different circulatory compartments.不同循环腔室血液中的循环微生物群。
华支睾吸虫感染可导致猫胆管上皮发生病理性改变，并改变胆汁微生物群组成。
Parasite. 2024;31:53. doi: 10.1051/parasite/2024053. Epub 2024 Sep 6.
4
The clinical relevance of acute-on-chronic liver failure in medical procedures: Endoscopy, interventions and surgery.急性-on-慢性肝衰竭在医疗程序中的临床相关性：内镜检查、介入治疗和手术。 （注：这里“acute-on-chronic”表述有误，可能是“acute-on-chronic liver failure”，应译为“慢加急性肝衰竭” ，整句准确译文应为：慢加急性肝衰竭在医疗程序中的临床相关性：内镜检查、介入治疗和手术。 ）
Liver Int. 2025 Mar;45(3):e15749. doi: 10.1111/liv.15749. Epub 2023 Sep 27.
5
The intestinal and biliary microbiome in autoimmune liver disease-current evidence and concepts.自身免疫性肝病的肠道和胆道微生物组学：现有证据和概念。
Semin Immunopathol. 2022 Jul;44(4):485-507. doi: 10.1007/s00281-022-00936-6. Epub 2022 May 10.
6
Biliary Diseases from the Microbiome Perspective: How Microorganisms Could Change the Approach to Benign and Malignant Diseases.从微生物组角度看胆道疾病：微生物如何改变良性和恶性疾病的治疗方法
Microorganisms. 2022 Jan 28;10(2):312. doi: 10.3390/microorganisms10020312.
7
The Microbiome in Autoimmune Liver Diseases: Metagenomic and Metabolomic Changes.自身免疫性肝病中的微生物组：宏基因组学和代谢组学变化
Front Physiol. 2021 Oct 8;12:715852. doi: 10.3389/fphys.2021.715852. eCollection 2021.
8
Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy.肝硬化门静脉高压症：病理生理机制与治疗
JHEP Rep. 2021 Jun 4;3(4):100316. doi: 10.1016/j.jhepr.2021.100316. eCollection 2021 Aug.
Gut. 2019 Mar;68(3):578-580. doi: 10.1136/gutjnl-2018-316227. Epub 2018 Mar 26.
4
Primary sclerosing cholangitis - a comprehensive review.原发性硬化性胆管炎——全面综述。
J Hepatol. 2017 Dec;67(6):1298-1323. doi: 10.1016/j.jhep.2017.07.022. Epub 2017 Aug 10.